7 months ago
SEBI Approves 13 IPOs Including Sai Parenteral
The Securities and Exchange Board of India (SEBI) has approved the initial public offerings (IPOs) of 13 companies, including Sai Parenteral, Hella Infra Market, and Sify Infinit Spaces.
Sai Parenteral plans to use the funds for expanding their factories, research, paying back loans, and buying another company.
They make medicines and sell them in many countries.
Hella Infra Market's IPO is set at ₹5,000 crore, but the details are not public yet.
Sify Infinit Spaces will raise ₹3,700 crore through a mix of fresh equity and offer for sale (OFS).
Other companies like Oswal Cables, UKB Electronics, and Medicap Healthcare also received approvals for their IPOs.
This is a big step for these companies to grow their businesses.
SEBI approved IPOs for 13 companies, including Sai Parenteral, Hella Infra Market, and Sify Infinit Spaces.
Sai Parenteral's IPO includes a fresh issue of ₹285 crore and an offer-for-sale of 35,00,000 shares.
Hella Infra Market's IPO is set at ₹5,000 crore, filed through a confidential route with details not public.
Sify Infinit Spaces' IPO consists of a fresh issue of ₹2,500 crore and an OFS of ₹1,200 crore.
Sai Parenteral plans to use the funds for capacity expansion, R&D, repayment of borrowings, working capital, and acquisition.
- Who
- Sai Parenteral, Hella Infra Market, Sify Infinit Spaces, Oswal Cables, UKB Electronics, CMR Green Technologies, Medicap Healthcare, Purple Style Labs, BVG India, Pride Hotels, Commtel Networks, Transline Technologies, Jay Jagdamba
- What
- Received SEBI approval for IPOs
- Where
- India
- When
- January 2026
- Why
- To raise funds for business expansion and other purposes
Key facts
- Companies
- Sai Parenteral, Hella Infra Market, Sify Infinit Spaces, Oswal Cables, UKB Electronics, CMR Green Technologies, Medicap Healthcare, Purple Style Labs, BVG India, Pride Hotels, Commtel Networks, Transline Technologies, Jay Jagdamba
- Regulator
- Securities and Exchange Board of India (SEBI)
- Sai Parenteral IPO Details
- Fresh issue of ₹285 crore, offer-for-sale of 35,00,000 shares
- Hella Infra Market IPO Details
- ₹5,000 crore, filed through a confidential route, details not public
- Sify Infinit Spaces IPO Details
- Fresh issue of ₹2,500 crore, OFS of ₹1,200 crore
- Sai Parenteral Fund Usage
- Capacity expansion, R&D, borrowings repayment, working capital, acquisition, general corporate purposes
- Sai Parenteral Business
- Pharmaceutical formulations, CDMO products and services
- Sai Parenteral Export Markets
- Australia, New Zealand, Southeast Asia, Middle East, Africa
Timeline
SEBI eases IPO dilution norms, letting giants sell fewer shares.
Then, it relaxes minimum public float rules for large listings.
On 2026-01-16, SEBI unveils stricter IPO disclosure rules.
In response, it approves IPOs for Sai Parenteral and Hella Infra Market on 2026-01-23.
These IPOs aim to raise funds for business expansion.
Sources
Hella Infra, Sify Infinit Space: IPO pipeline builds as SEBI approves 13 issues across infrastructure, tech, FMCG
Infra.Market, Purple Style Labs and 10 other firms get Sebi nod to float IPOs
SEBI clears IPOs of 13 companies this week
Upcoming IPOs: Sai Parenteral and Hella Infra Market get Sebi nod to raise funds via public issue
